Mesenchymal stem cells: New players in retinopathy therapy
Retinopathies in human and animal models have shown to occur through loss of pericytes resulting in edema formation, excessive immature retinal angiogenesis, and neuronal apoptosis eventually leading to blindness. In recent years, the concept of regenerating terminally differentiated organs with a c...
Main Author: | Rajashekhar eGangaraju |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00059/full |
Similar Items
-
Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside
by: Serhiy Forostyak, et al.
Published: (2017-10-01) -
Perivascular mesenchymal stem cells in the adult human brain: a future target for neuroregeneration?
by: Ilknur Özen, et al.
Published: (2012-12-01) -
Mesenchymal stem cell therapy for intractable neonatal disorders
by: So Yoon Ahn, et al.
Published: (2021-02-01) -
Five Decades Later, Are Mesenchymal Stem Cells Still Relevant?
by: Mario Gomez-Salazar, et al.
Published: (2020-02-01) -
Stem cells in dentistry, sources, and applications
by: Mozafar Khazaei, et al.
Published: (2016-01-01)